3/28
08:06 am
xers
Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $5.00 price target on the stock.
Medium
Report
Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $5.00 price target on the stock.
3/28
06:50 am
xers
Rating for XERS
Medium
Report
Rating for XERS
3/28
06:50 am
xers
Rating for XERS
Medium
Report
Rating for XERS